- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02792972
Antiseptic and Analgesic Action Acmella Oleracea Skin: Randomized Clinical Trial
June 7, 2016 updated by: Ana Beatriz Alkimim Teixeira Loyola
Context: Research on natural products with therapeutic, analgesic or antimicrobial purpose should be encouraged to create new drugs.
Acmella oleracea, typical plant of the Northern region of the country and popularly known as jambu, has aroused the interest of researchers because of its therapeutic potential.
Objective: To evaluate the potential topical analgesic and antimicrobial of Acmella oleracea plant extract from the skin antisepsis in venipuncture procedures.
Methods: This is a clinical, randomized, controlled trial with healthy volunteers recruited at the Clinic I of the collection of biological materials sector of the Hospital das Clinicas Samuel Libânio, in Pouso Alegre-MG.
The plant extract A. oleracea manipulated with Transcutol® and 70% alcohol were used in the volunteers before the venipuncture procedure as allocation in study groups.
Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Context: Research on natural products with therapeutic, analgesic or antimicrobial purpose should be encouraged to create new drugs.
Acmella oleracea, typical plant of the Northern region of the country and popularly known as jambu, has aroused the interest of researchers because of its therapeutic potential.
Objective: To evaluate the potential topical analgesic and antimicrobial of Acmella oleracea plant extract from the skin antisepsis in venipuncture procedures.
Methods: This is a clinical, randomized, controlled trial with healthy volunteers recruited at the Clinic I of the collection of biological materials sector of the Hospital das Clinicas Samuel Libânio, in Pouso Alegre-MG.
The plant extract A. oleracea manipulated with Transcutol® and 70% alcohol were used in the volunteers before the venipuncture procedure as allocation in study groups.
Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- healthy volunteers
- without restriction as to ethnicity
- educational level and social class who agreed to participate by signing the Informed Consent and Informed (IC )
Exclusion Criteria:
- pregnant women (due to contractile properties that can cause )
- cancer patients
- chronic and refusal to participate in the study kidney
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Acmella oleracea
The plant extract A. oleracea manipulated with Transcutol® were used in the volunteers 3 minutes before the venipuncture
|
The plant extract A. oleracea manipulated with Transcutol® were used in the volunteers before the venipuncture procedure as allocation in study groups.
Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.
Other Names:
|
Placebo Comparator: alcohol 70%
70% alcohol were used in the volunteers 3 minutes before the venipuncture
|
70% alcohol were used in the volunteers before the venipuncture procedure as allocation in study groups.
Held collection of skin microbiota by the swab technique and the end of the venipuncture procedure was applied to the volunteer, the visual numeric scale (VNS) standard to determine the degree of pain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The degree of pain in 15 healthy volunteers will be measured by the visual numeric scale (VNS) standard immediately after the venipuncture procedure.
Time Frame: 1 day
|
1 day
|
The skin microflora in 15 healthy volunteers will be measured counted the microorganism isolated by swab technique and plated on plates containing the medium Standard Methods Agar (PCA).
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Ana Beatriz A Teixeira Loyola, doctor, Universidade do Vale do Sapucai
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
September 1, 2015
Study Completion (Actual)
September 1, 2015
Study Registration Dates
First Submitted
May 23, 2016
First Submitted That Met QC Criteria
June 7, 2016
First Posted (Estimate)
June 8, 2016
Study Record Updates
Last Update Posted (Estimate)
June 8, 2016
Last Update Submitted That Met QC Criteria
June 7, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Carol2014
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesic
-
Algemeen Ziekenhuis Maria MiddelaresRecruiting
-
Hospices Civils de LyonCompleted
-
University Hospital TuebingenUnknown
-
Cukurova UniversityErzincan UniversityCompleted
-
Algemeen Ziekenhuis Maria MiddelaresNot yet recruiting
-
Ain Shams UniversityCompleted
-
Second Hospital of Shanxi Medical UniversityRecruitingOpioid Analgesic Adverse ReactionChina
-
Albany Medical CollegeRecruitingAnalgesic Adverse ReactionUnited States
-
Al-Azhar UniversityCompletedTotal Hip Arthroplasty | The Analgesic EfficacyEgypt
-
University Hospital, AkershusCompletedCesarean Delivery Affecting Newborn | Analgesic Adverse ReactionNorway
Clinical Trials on A. oleracea
-
Khon Kaen UniversityNot yet recruitingOral MucosaThailand
-
Universidade Federal do ParaCompletedPain | Tooth Bleaching | Dentin Desensitizing AgentsBrazil
-
Federal University of São PauloCasa de Saúde São José; Rafael R. Caiado; Acácio Alves Souza Lima-Filho; Eduardo... and other collaboratorsCompletedDiabetic Retinopathy | Epiretinal Membrane | Macular HoleBrazil
-
The Gut Microbiome Center (Centar za crijevni mikrobiom)University of ZagrebCompletedGastrointestinal MicrobiomeCroatia
-
Qazvin University Of Medical SciencesCompletedLichen Planus, OralIran, Islamic Republic of
-
Azienda di Servizi alla Persona di PaviaCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedCorneal Infiltrative Events | Corneal InflammationUnited States
-
Verifomics LLCTerminatedObesity | Arthritis | Arthralgia | Migraine Disorders | Sleep Initiation and Maintenance Disorders | Anxiety | Rhinitis | Rhinitis, Allergic | Respiratory Sounds | Headache | Sleep Deprivation | DyspneaUnited States